OTUB1/USP8-IN-1
OTUB1/USP8-IN-1 is a potent dual OTUB1/USP8 inhibitor with IC50 values of 0.17 and 0.28 nM for OTUB1 and USP8, respectively. OTUB1/USP8-IN-1 can be used in research of cancer[1].
Product Specifications
CAS Number
[2858800-98-1]
UNSPSC
12352005
Target
Deubiquitinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/otub1-usp8-in-1.html
Purity
98.31
Solubility
DMSO : 50 mg/mL (ultrasonic) |H2O : 4.07 mg/mL (ultrasonic; warming; adjust pH to 3 with 1 M HCl; heat to 60°C)
Smiles
O=C(C1=C2OC(C3=C(F)C=CC(O[C@H]4CN(C)CC4)=C3Cl)=N1)C5=C(C=CC=C5)C2=O
Molecular Formula
C22H16ClFN2O4
Molecular Weight
426.82
References & Citations
[1]Tan L, et, al. Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer. J Med Chem. 2022 Oct 11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
IL16 (IL-16, Pro-interleukin-16, Lymphocyte Chemoattractant Factor, LCF, FLJ16806, FLJ42735, FLJ44234) (MaxLight 405)
IL16 (IL-16, Pro-interleukin-16, Lymphocyte Chemoattractant Factor, LCF, FLJ16806, FLJ42735, FLJ44234) (MaxLight 405)
DYM (Dymeclin, Dyggve-Melchior-Clausen Syndrome Protein, FLJ20071, FLJ90130) (MaxLight 750) discontinued
